Moderated Poster Discussions - T2 Research/Science

Tuesday, April 15, 2025
2:10 pm - 3:20 pm

T2 Research/Science: Translation to patients, including Phase 2 and 3 clinical trials, and controlled studies leading to clinical application and evidence-based guidelines.

CAN WE IMPLANT AND PACE WITH A NOVEL INTERCOSTAL EXTRAVASCULAR TEMPORARY PACING LEAD? (Cardiology / Cardiovascular Disease)
Aidan Faller, BS, Midwestern University
A novel intercostal extravascular pacing lead (EV-TP) (AtaCor Medical, San Clemente, CA) iteratively designed to function with a market-released temporary pacemaker has been developed for pacing. The distal end of the lead is designed to contact the pericardium from within the mediastinum. Clinical data have been analyzed to characterize procedure success and pacing capture thresholds up to 2 days after insertion using the final lead design.

NAVIGATING THE RETURN OF INDIVIDUAL RESEARCH RESULTS: INSIGHTS FROM A MULTI-SITE COHORT STUDY (Pulmonary / Critical Care)
Denise Kent, PhD, APRN, University of Illinois Chicago
The return of individual research results (IRR) to participants presents opportunities and challenges. As the National Academy of Science, Engineering and Medicine (NASEM) published, there is potential value in sharing clinically relevant results with participants. However, with minimal guidelines and no best practices for how to return IRRs, research teams face complex ethical, logistical, and practical considerations. This multi-site study (UIC IRB No. 2024- 0782)describes the return of IRRs (e.g., lab, spirometry, chest CT) within a NHLBI funded study, Lung Health Cohort (LHC) (U01 HL146408-01). The LHC study is conducted by the American Lung Association, Airways Clinical Research Centers.